• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Fungi (Basel) . Clinical and Microbiological Characteristics of Culture-Positive, Influenza-Associated Pulmonary Aspergillosis: A Single-Center St

tetano

Editor, Senior Moderator
J Fungi (Basel)


. 2022 Jan 4;8(1):49.
doi: 10.3390/jof8010049.
Clinical and Microbiological Characteristics of Culture-Positive, Influenza-Associated Pulmonary Aspergillosis: A Single-Center Study in Southern Taiwan, 2016-2019


Chi-Jung Wu[SUP] 1 2 [/SUP], Cong-Tat Cia[SUP] 3 [/SUP], Hsuan-Chen Wang[SUP] 1 [/SUP], Chang-Wen Chen[SUP] 3 4 [/SUP], Wei-Chieh Lin[SUP] 3 [/SUP], Jen-Chieh Lee[SUP] 3 [/SUP], Po-Sheng Chen[SUP] 3 [/SUP], Chih-Cheng Hsieh[SUP] 3 [/SUP], Wei-Ting Li[SUP] 3 [/SUP], Po-Lan Su[SUP] 5 [/SUP], Xin-Min Liao[SUP] 5 [/SUP], Ming-I Hsieh[SUP] 1 [/SUP], Pui-Ching Choi[SUP] 1 [/SUP], Wen-Chien Ko[SUP] 2 4 [/SUP]



Affiliations

Abstract

This study delineated the characteristics of 24 (11.2%) culture-positive, influenza-associated pulmonary aspergillosis (IAPA) patients out of 215 patients with severe influenza during 2016-2019 in a medical center in southern Taiwan. Twenty (83.3%) patients did not have EORTC/MSG-defined host factors. The mean time from influenza diagnosis to Aspergillus growth was 4.4 days, and 20 (83.3%) developed IAPA within seven days after influenza diagnosis. All patients were treated in intensive care units and all but one (95.8%) received mechanical ventilation. Aspergillus tracheobronchitis was evident in 6 (31.6%) of 19 patients undergoing bronchoscopy. Positive galactomannan testing of either serum or bronchoalveolar lavage was noted in all patients. On computed tomography imaging, IAPA was characterized by peribronchial infiltrates, multiple nodules, and cavities superimposed on ground-glass opacities. Pure Aspergillus growth without bacterial co-isolation in culture was found in 17 (70.8%) patients. A. fumigatus (15, 62.5%), A. flavus (6, 25.0%), and A. terreus (4, 16.7%) were the major causative species. Three patients had mixed Aspergillus infections due to two species, and two had mixed azole-susceptible and azole-resistant A. fumigatus infection. All patients received voriconazole with an all-cause mortality of 41.6%. Of 14 survivors, the mean duration of antifungal use was 40.5 days. In conclusion, IAPA is an early and rapidly deteriorating complication following influenza that necessitates clinical vigilance and prompt diagnostic workup.

Keywords: Aspergillus flavus; Aspergillus fumigatus; Aspergillus terreus; Taiwan; aspergillosis; azole resistance; bronchoscopy; galactomannan; influenza; radiology; tracheobronchitis.
 
Back
Top Bottom